IL102174A0IL102174AIL10217492AIL102174A0IL 102174 A0IL102174 A0IL 102174A0IL 102174 AIL102174 AIL 102174AIL 10217492 AIL10217492 AIL 10217492AIL 102174 A0IL102174 A0IL 102174A0
Authority
IL
Israel
Prior art keywords
oxo
naphthyridine
quinoline
carboxylic acid
acid derivatives
Prior art date
Application number
IL102174A
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL84105Aexternal-prioritypatent/IL84105A0/en
Application filed by Bristol Myers Squibb CofiledCriticalBristol Myers Squibb Co
Priority to IL102174ApriorityCriticalpatent/IL102174A0/en
Publication of IL102174A0publicationCriticalpatent/IL102174A0/en